Millennium Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269M Buy
919,171
+466,051
+103% +$153M 0.11% 154
2025
Q4
$159M Buy
453,120
+301,698
+199% +$102M 0.07% 265
2025
Q3
$48.9M Buy
151,422
+70,270
+87% +$21.9M 0.02% 890
2025
Q2
$31.6M Buy
81,152
+71,423
+734% +$28.7M 0.02% 1150
2025
Q1
$4.23M Sell
9,729
-240,336
-96% -$96.5M ﹤0.01% 3027
2024
Q4
$92.2M Buy
250,065
+2,061
+0.8% +$862K 0.05% 432
2024
Q3
$129M Sell
248,004
-295,197
-54% -$158M 0.06% 314
2024
Q2
$294M Sell
543,201
-171,305
-24% -$90.5M 0.14% 110
2024
Q1
$370M Sell
714,506
-43,481
-6% -$21.6M 0.16% 80
2023
Q4
$357M Sell
757,987
-231,392
-23% -$107M 0.15% 80
2023
Q3
$431M Buy
989,379
+764,160
+339% +$347M 0.22% 47
2023
Q2
$100M Sell
225,219
-96,712
-30% -$44.6M 0.05% 364
2023
Q1
$148M Buy
321,931
+33,542
+12% +$16M 0.08% 189
2022
Q4
$148M Buy
288,389
+34,421
+14% +$17.5M 0.08% 237
2022
Q3
$115M Buy
253,968
+244,691
+2,638% +$117M 0.07% 270
2022
Q2
$4.48M Sell
9,277
-142,002
-94% -$70.2M ﹤0.01% 2918
2022
Q1
$74.3M Buy
151,279
+22,865
+18% +$10.5M 0.04% 476
2021
Q4
$59.5M Buy
128,414
+70,275
+121% +$29.6M 0.03% 626
2021
Q3
$21.7M Sell
58,139
-81,527
-58% -$31M 0.01% 1249
2021
Q2
$53.3M Sell
139,666
-72,355
-34% -$27.7M 0.03% 572
2021
Q1
$76.1M Buy
212,021
+176,974
+505% +$56.9M 0.05% 329
2020
Q4
$11.3M Sell
35,047
-43,740
-56% -$13.4M 0.01% 1602
2020
Q3
$21.2K Sell
78,787
-306,978
-80% -$82.6M 0.03% 763
2020
Q2
$101M Buy
385,765
+67,201
+21% +$17.9M 0.14% 106
2020
Q1
$72.3M Buy
318,564
+26,878
+9% +$7.32M 0.16% 104
2019
Q4
$88.1M Buy
291,686
+40,347
+16% +$11.1M 0.11% 176
2019
Q3
$60.3M Buy
+251,339
New +$68.9M 0.1% 237
2019
Q2
Sell
-618,760
Closed -$169M 4141
2019
Q1
$178M Buy
618,760
+351,728
+132% +$102M 0.27% 39
2018
Q4
$70.1M Sell
267,032
-12,806
-5% -$3.52M 0.11% 232
2018
Q3
$76.7M Sell
279,838
-76,089
-21% -$19.8M 0.09% 258
2018
Q2
$84.7M Buy
355,927
+175,584
+97% +$40.7M 0.11% 228
2018
Q1
$39.6M Sell
180,343
-252,321
-58% -$59.3M 0.05% 522
2017
Q4
$97.4M Buy
432,664
+194,789
+82% +$41.5M 0.13% 165
2017
Q3
$45.2M Sell
237,875
-435,065
-65% -$82.8M 0.07% 382
2017
Q2
$127M Buy
672,940
+457,015
+212% +$82.1M 0.23% 79
2017
Q1
$35.7M Sell
215,925
-640,367
-75% -$102M 0.07% 426
2016
Q4
$123M Buy
856,292
+558,308
+187% +$74.8M 0.26% 55
2016
Q3
$37.3M Sell
297,984
-139,736
-32% -$18M 0.06% 329
2016
Q2
$57.5M Sell
437,720
-35,559
-8% -$4.87M 0.13% 168
2016
Q1
$65.8M Buy
473,279
+410,079
+649% +$54.8M 0.16% 128
2015
Q4
$8.81M Sell
63,200
-37,231
-37% -$5.13M 0.02% 994
2015
Q3
$14.1M Sell
100,431
-391,244
-80% -$58.8M 0.03% 744
2015
Q2
$80.7M Buy
+491,675
New +$78.6M 0.15% 130
2015
Q1
Sell
-628,412
Closed -$79M 3713
2014
Q4
$79M Buy
628,412
+495,772
+374% +$61.3M 0.17% 113
2014
Q3
$15.9M Buy
132,640
+424
+0.3% +$48.6K 0.04% 610
2014
Q2
$14.2M Buy
+132,216
New +$13.6M 0.04% 639
2014
Q1
Sell
-138,541
Closed -$12.8M 3557
2013
Q4
$12.8M Buy
138,541
+108,315
+358% +$9.62M 0.04% 552
2013
Q3
$2.53M Sell
30,226
-66,145
-69% -$5.67M 0.01% 1537
2013
Q2
$7.89M Buy
+96,371
New +$7.21M 0.02% 756

Other funds holding ELV

Millennium Management's ELV Position: Q1 2026 in Review

Millennium Management increased its Elevance Health (ELV) stake by 103% in Q1 2026, buying an estimated $153M and bringing the position to 919,171 shares worth $269M. The position accounts for 0.11% of the portfolio, ranked #154.

Millennium Management first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $431M in Q3 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Millennium Management held 919,171 shares of Elevance Health worth $269M as of Q1 2026.
  • Millennium Management bought 466,051 Elevance Health shares in Q1 2026, an estimated $153M.
  • Elevance Health made up 0.11% of Millennium Management's portfolio in Q1 2026, its #154 holding.
  • Millennium Management first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
  • Millennium Management's Elevance Health position peaked at $431M in Q3 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.